Anthera Pharmaceuticals Inc (ANTH) [Rocket]

In millions, except per share items	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Sep-09-13	Dec-31-12	Sep-09-12
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues [+]	36.5	0.1	3.2	0.0	0.0	238.5	0.0	216.8
Royalties						237.0	49.2	215.3
Services		0.0	0.6
License and services		0.1	2.6
Revenue growth	25094.5%	-95.4%				10.0%		29.3%
Cost of goods sold	0.0	-57.6	-41.1	0.0	0.0	274.3	0.0	216.8
Gross profit	36.5	57.7	44.3	0.0	0.0	-35.9	0.0	0.0
Gross margin	100.0%	39812.4%	1389.4%			-15.0%		0.0%
Selling, general and administrative [+]	7.9	11.1	7.6	6.6	6.6	37.4	55.9	30.8
General and administrative	7.9	11.1	7.6	6.6	6.6	37.4		30.8
Research and development	28.6	46.5	33.5	21.8	21.7
Other operating expenses	36.4	57.3	38.4			201.1	-14.2	215.3
EBITDA [+]	-36.2	-56.9	-35.0	-28.1	-27.9	-273.5	-41.4	-245.6
EBITDA growth	-36.5%	62.8%	24.3%	0.8%	-32.6%	11.4%	-55.5%	29.3%
EBITDA margin	-99.0%	-39249.0%	-1097.6%			-114.7%		-113.3%
Depreciation and amortization	0.3	0.3	0.3	0.3	0.4	0.9	0.3	0.5
EBIT [+]	-36.4	-57.2	-35.2	-28.5	-28.2	-274.3	-41.7	-246.1
EBIT growth	-36.3%	62.2%	23.8%	0.8%	-32.3%	11.5%	-55.2%	29.4%
EBIT margin	-99.7%	-39432.4%	-1106.5%			-115.0%		-113.5%
Interest expense, net [+]				1.0	2.6	10.3		7.7
Interest expense				1.0	2.6	10.3	0.1	7.7
Interest income							0.1
Other income (expense), net [+]	9.6	1.7	0.0	-0.1	0.0	-2.6	-3.6	-6.6
Change in fair value of warrants	-0.6
Other	-0.1	-0.1	0.0	-0.1	0.0		-3.5
Pre-tax income	-26.9	-55.5	-35.2	-29.6	-30.9	-287.2	-45.3	-260.4
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-29.4	-66.4	-35.2	-29.6	-30.9	-287.2	-45.3	-260.4
Net margin	-80.4%	-45818.6%	-1105.8%			-120.4%		-120.1%

Basic EPS [+]	($2.86)	($12.87)	($7.91)	($1.36)	($1.69)		($6.27)
Growth	-77.8%	62.7%	481.7%	-19.5%	-73.1%		-69.2%
Diluted EPS [+]	($2.86)	($12.87)	($7.91)	($1.36)	($1.69)		($6.27)
Growth	-77.8%	62.7%	481.7%	-19.5%	-73.1%		-69.2%

Shares outstanding (basic) [+]	10.3	5.2	4.5	21.8	18.3		7.2
Growth	99.0%	15.9%	-79.5%	19.2%	152.8%		54.5%
Shares outstanding (diluted) [+]	10.3	5.2	4.5	21.8	18.3		7.2
Growth	99.0%	15.9%	-79.5%	19.2%	152.8%		54.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.